Literature DB >> 8471031

Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.

A Hall1, H Dalbøge, A Grubb, M Abrahamson.   

Abstract

Human cystatin C variants in which the evolutionarily conserved Gly-11 residue has been replaced by residues with positively charged (Arg), negatively charged (Glu), bulky hydrophobic (Trp), or small (Ser or Ala) side-chains have been produced by site-directed mutagenesis and expression in Escherichia coli. The five variants were isolated and structurally verified. Their inhibitory properties were compared with those of wild-type recombinant cystatin C by determination of the equilibrium constants for dissociation (Ki) of their complexes with the cysteine endopeptidases papain and human cathepsin B and with the cysteine exopeptidase dipeptidyl peptidase I. The Ser-11 and Ala-11 cystatin C variants displayed Ki values for the two endopeptidases that were approx. 20-fold higher than those of wild-type cystatin C, while the corresponding values for the Trp-11. Arg-11 and Glu-11 variants were increased by a factor of about 2000. In contrast, the Ki values for the interactions of all five variants with the exopeptidase differed from that of wild-type cystatin C by a factor of less than 10. Wild-type cystatin C and the Ser-11, Ala-11 and Glu-11 variants were incubated with neutrophil elastase, which in all cases resulted in the rapid hydrolysis of a single peptide bond, between amino acid residues 10 and 11. The Ki values for the interactions with papain of these three N-terminal-decapeptide-lacking cystatin C variants were 20-50 nM, just one order of magnitude higher than the value for N-terminally truncated wild-type cystatin C, which in turn was similar to the corresponding values for the full-length Glu-11, Arg-11 and Trp-11 variants. These data indicate that the crucial feature of the conserved Gly residue in position 11 of wild-type cystatin C is that this residue, devoid of a side-chain, will allow the N-terminal segment of cystatin C to adopt a conformation suitable for interaction with the substrate-binding pockets of cysteine endopeptidases, resulting in high-affinity binding and efficient inhibition. The functional properties of the remaining part of the proteinase contact area, which is built from more C-terminal inhibitor segments, are not significantly affected even when amino acids with bulky or charged side-chains replace the Gly-11 residue of the N-terminal segment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471031      PMCID: PMC1132490          DOI: 10.1042/bj2910123

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Agarose gel electrophoresis.

Authors:  J O Jeppsson; C B Laurell; B Franzén
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

2.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.

Authors:  P J Henderson
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Partial amino acid sequence of two forms of human post-gamma-globulin.

Authors:  C Tonnelle; A Colle; M Fougereau; Y Manuel
Journal:  Biochem Biophys Res Commun       Date:  1979-02-14       Impact factor: 3.575

5.  Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor.

Authors:  F Gauthier; U Fryksmark; K Ohlsson; J G Bieth
Journal:  Biochim Biophys Acta       Date:  1982-01-18

6.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

7.  Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis.

Authors:  A Grubb; H Löfberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length.

Authors:  A Hall; M Abrahamson; A Grubb; J Trojnar; P Kania; R Kasprzykowska; F Kasprzykowski
Journal:  J Enzyme Inhib       Date:  1992

9.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.

Authors:  M J Zoller; M Smith
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

10.  The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors.

Authors:  A J Barrett; M E Davies; A Grubb
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

View more
  15 in total

1.  Immunomodulatory peptide from cystatin, a natural cysteine protease inhibitor, against leishmaniasis as a model macrophage disease.

Authors:  Snigdha Mukherjee; Anindita Ukil; Pijush K Das
Journal:  Antimicrob Agents Chemother       Date:  2007-03-05       Impact factor: 5.191

2.  Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.

Authors:  R W Mason; K Sol-Church; M Abrahamson
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  The crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine model.

Authors:  Michalis Kotsyfakis; Helena Horka; Jiri Salat; John F Andersen
Journal:  Mol Microbiol       Date:  2010-06-01       Impact factor: 3.501

4.  Parasite-specific immunomodulatory functions of filarial cystatin.

Authors:  Peter Schierack; Richard Lucius; Bettina Sonnenburg; Klaus Schilling; Susanne Hartmann
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS.

Authors:  B Asgeirsson; S Haebel; L Thorsteinsson; E Helgason; K O Gudmundsson; G Gudmundsson; P Roepstorff
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

6.  Identification of cystatin SA as a novel inhibitor of acid ceramidase.

Authors:  Efrat Eliyahu; Nataly Shtraizent; Xingxuan He; Dafna Chen; Ruth Shalgi; Edward H Schuchman
Journal:  J Biol Chem       Date:  2011-08-16       Impact factor: 5.157

Review 7.  Macrophage immunomodulation in chronic osteolytic diseases-the case of periodontitis.

Authors:  Corneliu Sima; Ana Viniegra; Michael Glogauer
Journal:  J Leukoc Biol       Date:  2018-11-19       Impact factor: 4.962

8.  Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy.

Authors:  M Abrahamson; A Grubb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines.

Authors:  Belen Tizon; Susmita Sahoo; Haung Yu; Sebastien Gauthier; Asok R Kumar; Panaiyur Mohan; Matthew Figliola; Monika Pawlik; Anders Grubb; Yasuo Uchiyama; Urmi Bandyopadhyay; Ana Maria Cuervo; Ralph A Nixon; Efrat Levy
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.

Authors:  E Pol; S L Olsson; S Estrada; T W Prasthofer; I Björk
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.